These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3988880)

  • 1. The contribution of subclinical cancer to Denver's high prostatic cancer incidence rate.
    Beckner M; Berg JW; Franz LW
    J Chronic Dis; 1985; 38(3):225-31. PubMed ID: 3988880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era.
    Konety BR; Bird VY; Deorah S; Dahmoush L
    J Urol; 2005 Nov; 174(5):1785-8; discussion 1788. PubMed ID: 16217287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognosis of incidental (stage A) prostatic cancer].
    Uchida T; Go M; Egawa S; Ao T; Kuwao S; Yokoyama E; Mashimo S; Endo T; Koshiba K
    Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1293-300. PubMed ID: 7689124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International trends in prostatic cancer.
    Zaridze DG; Boyle P; Smans M
    Int J Cancer; 1984 Feb; 33(2):223-30. PubMed ID: 6693200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An epidemiological survey of prostatic cancer from the Annual of the Pathological Autopsy Cases in Japan.
    Araki H; Mishina T; Miyakoda K; Fujiwara T; Kobayashi T
    Tohoku J Exp Med; 1980 Feb; 130(2):159-64. PubMed ID: 7385225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rise in prostatic cancer incidence associated with increased use of transurethral resection.
    Potosky AL; Kessler L; Gridley G; Brown CC; Horm JW
    J Natl Cancer Inst; 1990 Oct; 82(20):1624-8. PubMed ID: 2213903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostatic cancer: pathological analysis of autopsied cases].
    Takahashi Y; Mayuzumi T; Satoh J
    Hinyokika Kiyo; 1986 Jun; 32(6):835-9. PubMed ID: 3766343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prostatic carcinoma. Incidence and significance of stage I - preclinical carcinoma].
    Schmassmann A; Mihatsch MJ
    Urologe A; 1983 Sep; 22 Suppl():388-92. PubMed ID: 6685389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathological study of latent carcinoma--with special reference to prostatic cancer].
    Moriwaki S; Yamamoto Y; Takashima S; Uyama K; Higa I; Kanayama H
    Gan No Rinsho; 1985 Jun; 31(7):847-53. PubMed ID: 2411968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidental adenocarcinoma after open prostatic adenectomy.
    Stillwell TJ; Malek RS; Engen DE; Farrow GM
    J Urol; 1989 Jan; 141(1):76-8. PubMed ID: 2462068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoplastic and borderline lesions of the prostate: autopsy study and epidemiological data.
    Silvestri F; Bussani R; Pavletic N; Bassan F
    Pathol Res Pract; 1995 Sep; 191(9):908-16. PubMed ID: 8606873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of stage a prostatic cancer detected incidentally by transurethral resection of the prostate].
    Nakanishi S; Gotou T; Sawada A; Shibasaki N; Ishitoya T; Okumura K
    Hinyokika Kiyo; 2009 Jan; 55(1):5-8. PubMed ID: 19227204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.
    Partin AW; Carter HB; Chan DW; Epstein JI; Oesterling JE; Rock RC; Weber JP; Walsh PC
    J Urol; 1990 Apr; 143(4):747-52. PubMed ID: 1690309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of care and follow-up of stages A1, B1 prostatic cancers from multicenter group, the National Prostatic Cancer Treatment Group (NPCTG).
    Murphy GP; Gaeta J; Priore R
    Urology; 1987 Mar; 29(3):258-61. PubMed ID: 3824720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective comparison of prostate cancer at autopsy and as a clinical event: the Hawaii Japanese experience.
    Stemmermann GN; Nomura AM; Chyou PH; Yatani R
    Cancer Epidemiol Biomarkers Prev; 1992; 1(3):189-93. PubMed ID: 1306104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer of the prostate in Norway 1957-1991--a descriptive study.
    Harvei S; Tretli S; Langmark F
    Eur J Cancer; 1996 Jan; 32A(1):111-7. PubMed ID: 8695216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of incidental prostatic cancer in Aust-Agder County, Norway.
    Waaler G; Ludvigsen TC; Stenwig AE
    Eur Urol; 1990; 18(3):179-83. PubMed ID: 1702057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of prostatic cancer.
    Hohbach C; Dhom G
    Scand J Urol Nephrol Suppl; 1980; 55():37-47. PubMed ID: 6938034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of grade of prostate cancer between pretreatment and autopsy].
    Ando K; Fuse H; Shimazaki J; Murakami S; Matsuzaki O
    Nihon Hinyokika Gakkai Zasshi; 1988 Aug; 79(8):1399-405. PubMed ID: 3246826
    [No Abstract]   [Full Text] [Related]  

  • 20. Stage at diagnosis and relative differences in breast and prostate cancer incidence in India: comparison with the United States.
    Hebert JR; Ghumare SS; Gupta PC
    Asian Pac J Cancer Prev; 2006; 7(4):547-55. PubMed ID: 17250425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.